Last reviewed · How we verify
monoclonal antibody 3H1 Alu Gel — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
monoclonal antibody 3H1 Alu Gel (monoclonal antibody 3H1 Alu Gel) — Alliance for Clinical Trials in Oncology.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| monoclonal antibody 3H1 Alu Gel TARGET | monoclonal antibody 3H1 Alu Gel | Alliance for Clinical Trials in Oncology | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- monoclonal antibody 3H1 Alu Gel CI watch — RSS
- monoclonal antibody 3H1 Alu Gel CI watch — Atom
- monoclonal antibody 3H1 Alu Gel CI watch — JSON
- monoclonal antibody 3H1 Alu Gel alone — RSS
Cite this brief
Drug Landscape (2026). monoclonal antibody 3H1 Alu Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/monoclonal-antibody-3h1-alu-gel. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab